PFE Stock Up 2.37%, Pfizer Begins Human Trials of COVID-19 Vaccine Candidate in U.S.

PFE Stock Up 2.37%, Pfizer Begins Human Trials of COVID-19 Vaccine Candidate in U.S.

Crypto New Media     •     May 6, 2020, 9:52 am

Crypto New Media Press On Monday, Pfizer announced it had dosed the first participants of the Phase 1/2 clinical trial for the coronavirus vaccine program in the U.S. In general, there will be 360…

Clickbank Affiliate Marketing